檢索結果 - Sarah Buchs
- Showing 1 - 3 results of 3
-
1
High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT)... 由 Benedikt Fritszching, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Nick Freemantle, Marco Contoli
發表在 Frontiers in Pediatrics (2023-03-01)獲取全文
Article -
2
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma – Authors´ reply 由 Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano, Nick Freemantle
發表在 The Lancet Regional Health. Europe (2022-06-01)獲取全文
Article -
3
Long-term health care resource and cost savings with allergy immunotherapy: REACT study results 由 Benedikt Fritzsching, MD, Celeste Porsbjerg, PhD, Marco Contoli, PhD, Sarah Buchs, MSc, Julie Rask Larsen, PhD, Nick Freemantle, PhD
發表在 Journal of Allergy and Clinical Immunology: Global (2024-02-01)獲取全文
Article